Prof. Dr. med. Andreas Schulze-Bonhage is a distinguished figure in the field of neurology and clinical neurophysiology, currently serving as the Head of the Epilepsy Center at the Neurocenter of the University Hospital Freiburg in Germany. With a strong academic background, he obtained his Doctor of Medicine (MD) degree in Neuroanatomy from Münster University in 1998, following his studies in Human Medicine at the same university from 1981 to 1987. Dr. Schulze-Bonhage furthered his academic pursuits by achieving his habilitation (PhD) in 2004 from the University of Freiburg, Germany, demonstrating his commitment to advancing knowledge in his field.

Throughout his illustrious career, Dr. Schulze-Bonhage has made significant contributions to epilepsy research and clinical practice. Since 1998, he has been instrumental in establishing and leading the Epilepsy Center at the Freiburg University Hospital, which stands as a European Reference Center renowned for its comprehensive care for pediatric and adult epilepsy patients, boasting the largest university-based presurgical program in Germany. His dedication to advancing epilepsy treatment is evidenced by his involvement in over 50 pharmacological multicenter trials and his coordination of trials in various neuromodulatory approaches, including Vagus Nerve Stimulation, Deep Brain Stimulation, and Focal Cortex Stimulation.

Dr. Schulze-Bonhage's clinical expertise spans over 25 years, during which he has been deeply involved in the outpatient and inpatient care of epilepsy patients across all age groups. He has also held esteemed editorial roles in prominent scientific journals such as "Epilepsia," "Seizure," "Clinical Neurophysiology," and "Clinical Epileptology," further cementing his influence in the academic community.

In addition to his clinical and editorial responsibilities, Dr. Schulze-Bonhage has been actively engaged in various scientific projects both nationally and internationally. As a project leader, he has contributed to groundbreaking studies focused on electrophysiological and imaging investigations in patients with focal epilepsy, seizure detection and prediction methods, neuromodulatory treatment approaches, and network analyses of the human brain.

With a prolific publication record boasting over 450 original publications in peer-reviewed journals, including prestigious outlets such as Science, Brain, Lancet Neurology, and JAMA Neurology, Dr. Schulze-Bonhage's impact on the field of epilepsy research is undeniable. His extensive body of work encompasses not only research articles but also reviews, book chapters, and editing contributions, solidifying his reputation as a leading authority in neurology and clinical neurophysiology.

In recognition of his outstanding contributions to the field, Dr. Schulze-Bonhage has received numerous accolades and honors throughout his career. His leadership roles, including serving as the President of the German Section of the International League Against Epilepsy (ILAE) from 2019 to 2021 and his membership in esteemed organizations such as the American Epilepsy Society and the European Brain and Behavioral Society, underscore his standing as a respected figure in the global epilepsy community.